These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30308952)

  • 1. Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: A Nationwide Drug Utilization Study.
    Rasmussen L; Bilenberg N; Thomsen Ernst M; Abitz Boysen S; Pottegård A
    J Clin Med; 2018 Oct; 7(10):. PubMed ID: 30308952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription Trends of Psychotropics in Children and Adolescents with Autism Based on Nationwide Health Insurance Data.
    Hong M; Lee SY; Han J; Park JC; Lee YJ; Hwangbo R; Chang H; Cho SW; Bhang SY; Kim B; Hwang JW; Bahn GH
    J Korean Med Sci; 2017 Oct; 32(10):1687-1693. PubMed ID: 28875615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of psychotropic agents used in autism spectrum disorder according to comorbidities in Turkey: A 4-year evaluation.
    Karabacak Y; Barun S; Vural İM; Vural E; Iseri E; Kahve AC; Yilmaz EŞ; Isli F; Turkes S; Ezber E; Paykal G
    Int Clin Psychopharmacol; 2023 Jul; 38(4):216-222. PubMed ID: 36752705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder.
    Madden JM; Lakoma MD; Lynch FL; Rusinak D; Owen-Smith AA; Coleman KJ; Quinn VP; Yau VM; Qian YX; Croen LA
    J Autism Dev Disord; 2017 Jan; 47(1):144-154. PubMed ID: 27817163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Psychotropic Medicine Use in Australian Children with Autism Spectrum Disorder: A Drug Utilization Study Based on Children Enrolled in the Longitudinal Study of Australian Children.
    Rasmussen L; Pratt N; Roughead E; Moffat A
    J Autism Dev Disord; 2019 Jan; 49(1):227-235. PubMed ID: 30136113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of psychotropic drugs in patients with autism spectrum disorders: a systematic review.
    Jobski K; Höfer J; Hoffmann F; Bachmann C
    Acta Psychiatr Scand; 2017 Jan; 135(1):8-28. PubMed ID: 27624381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.
    Bachmann CJ; Manthey T; Kamp-Becker I; Glaeske G; Hoffmann F
    Res Dev Disabil; 2013 Sep; 34(9):2551-63. PubMed ID: 23747941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014.
    Lopez-Leon S; Lopez-Gomez MI; Warner B; Ruiter-Lopez L
    Daru; 2018 Sep; 26(1):5-10. PubMed ID: 30159759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of psychotropic medication in children and adolescents with autism spectrum disorders.
    Coury DL; Anagnostou E; Manning-Courtney P; Reynolds A; Cole L; McCoy R; Whitaker A; Perrin JM
    Pediatrics; 2012 Nov; 130 Suppl 2():S69-76. PubMed ID: 23118256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
    Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
    Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Tic-Suppressing Medication and Other Psychotropic Drugs in Children and Adolescents with Newly Diagnosed Tic Disorders in Denmark.
    Rasmussen L; Bilenberg N; Thrane JM; Ernst MT; Pottegård A
    J Child Adolesc Psychopharmacol; 2020 Oct; 30(8):476-485. PubMed ID: 32882143
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark.
    Steinhausen HC; Bisgaard C
    Acta Psychiatr Scand; 2014 Mar; 129(3):221-31. PubMed ID: 23738593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics Associated with Drug Prescription and Compliance Among Young Children with Autism Spectrum Disorder.
    Meiri G; Azoulay H; Menashe I
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):232-237. PubMed ID: 29266976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide Study of Neuropsychiatric Comorbidity and Medicines Use in Children With Autism Spectrum Disorder in Norway.
    Kiselev Y; Handal M; Hjellvik V; Reichborn-Kjennerud T; Stoltenberg C; Suren P; Havdahl A; Skurtveit S
    Front Psychiatry; 2020; 11():596032. PubMed ID: 33363486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.